http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005222019-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7305354afee302fc308a2f279c007916
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46f7eb3894f6e25cdfecaf69e2827cdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fd59c423663682f32eeae43f7f9d408
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-523
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
filingDate 2002-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5ade7b5a3e09a77de4076f1605effcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e87cdabc8439874ab2ff331eda7ac1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9cd727626c8beeae9d2c47178490e03
publicationDate 2005-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2005222019-A1
titleOfInvention Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
abstract A preventive and/or therapeutic agent for post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening, wherein the agent contains, as an active ingredient, a monocyte chemoattractant protein-1 (MCP-1) function inhibitor. Administration of the MCP-1 function inhibitor enables prevention and treatment of post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening.
priorityDate 2001-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5705360-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5399346-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539

Total number of triples: 27.